Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis

L Foley, J Larkin, R Lombard-Vance, AW Murphy… - BMJ open, 2021 - bmjopen.bmj.com
Objectives This systematic review aimed to describe medication non-adherence among
people living with multimorbidity according to the current literature, and synthesise …

[HTML][HTML] Ethnic disparities in medication adherence? A systematic review examining the association between ethnicity and antidiabetic medication adherence

R Asiri, A Todd, A Robinson-Barella, A Husband - Plos one, 2023 - journals.plos.org
Objectives Adherence to prescribed medication is an essential component of diabetes
management to obtain optimal outcomes. Understanding the relationship between …

Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer

AI Neugut, X Zhong, JD Wright, M Accordino… - JAMA …, 2016 - jamanetwork.com
Importance While adjuvant hormonal therapy (HT) reduces mortality for women with
nonmetastatic breast cancer, nonadherence to HT is common. Objective We investigated the …

Diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study

LC Pinheiro, O Soroka, LM Kern, JP Leonard… - Cancer, 2020 - Wiley Online Library
Background Diabetes places patients with cancer at an increased risk of infections,
hospitalizations, and mortality. The objective of the current study was to characterize …

Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors

GS Calip, JG Elmore, DM Boudreau - Breast cancer research and …, 2017 - Springer
Objective Comorbidity among breast cancer survivors is prevalent, and adherence to
medication management of comorbidities may be important for both chronic disease and …

[HTML][HTML] Clinical and genetic determinants of cardiomyopathy risk among hematopoietic cell transplantation survivors

KJ Leger, K Cushing-Haugen, JA Hansen… - Biology of Blood and …, 2016 - Elsevier
Cardiomyopathy has been recognized as a complication after hematopoietic cell
transplantation (HCT). Using a nested case-cohort design, we examined the relationships …

Comorbidities and their management: potential impact on breast cancer outcomes

CC Hong, CB Ambrosone, PJ Goodwin - Improving outcomes for breast …, 2015 - Springer
Pre-existing comorbidities negatively impacts overall breast cancer prognosis, increasing
both breast cancer specific deaths as well as death from competing causes. Improvements …

[HTML][HTML] Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes

MMJ Zanders, HR Haak, MPP van Herk-Sukel… - Diabetologia, 2015 - Springer
Aims/hypothesis Adherence to glucose-lowering drug (GLD) treatment regimens is crucial
for metabolic control and improving prognosis. Because a diagnosis of cancer might have …

Secondary prevention of cardiovascular disease: unrecognized opportunity to improve survival in cancer patients

A Vallakati, B Konda - European Journal of Preventive …, 2023 - academic.oup.com
Cancer and cardiovascular disease (CVD) are the two leading causes of mortality
worldwide. 1 Advances in cardiovascular therapies have resulted in a remarkable decline in …

[HTML][HTML] Analysis of the incidence of Type 2 diabetes, requirement of insulin treatment, and diabetes-related complications among patients with cancer

SJ Lee, C Kim, H Yu, DK Kim - Cancers, 2023 - mdpi.com
Simple Summary Previous epidemiological studies have shown that type 2 diabetes may be
associated with an increased risk of several cancer types and cancer-related mortality …